Nanoparticles and microparticles as vaccine-delivery systems. - Wikidata - wikimedia - TriplyDB

Nanoparticles and microparticles as vaccine-delivery systems.

Nanoparticles and microparticles as vaccine-delivery systems.

http://www.wikidata.org/entity/Q36968297

about

Outer membrane vesicles as platform vaccine technology Self-assembling protein nanoparticles in the design of vaccines Programming the magnitude and persistence of antibody responses with innate immunity.Antigen vehiculization particles based on the Z protein of Junin virus.Yeast lysates carrying the nucleoprotein from measles virus vaccine as a novel subunit vaccine platform to deliver Plasmodium circumsporozoite antigen.Polymeric Materials for Gene Delivery and DNA Vaccination Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses.CD40mAb adjuvant induces a rapid antibody response that may be beneficial in post-exposure prophylaxis Delivery of foreign antigens by engineered outer membrane vesicle vaccines.Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain.The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus.Nanotoxoid Vaccines In vitro perforation of human epithelial carcinoma cell with antibody-conjugated biodegradable microspheres illuminated by a single 80 femtosecond near-infrared laser pulse.Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles Second international congress on immunopharmacology: delivery systems and current strategies for drug design.Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy.Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.Microparticle surface modifications targeting dendritic cells for non-activating applications.Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy.The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells Beyond antigens and adjuvants: formulating future vaccines.Design opportunities for actively targeted nanoparticle vaccines.Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.Cubosome nanoparticles potentiate immune properties of immunostimulants.Applications of nanomaterials as vaccine adjuvants.Engineering nano- and microparticles to tune immunity A polysaccharide isolated from Agaricus blazei Murill (ABP-AW1) as a potential Th1 immunity-stimulating adjuvant.Engineered Human Ferritin Nanoparticles for Direct Delivery of Tumor Antigens to Lymph Node and Cancer Immunotherapy.Physical approaches to biomaterial design.Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity.Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.Particle based vaccine formulations for transcutaneous immunization Nucleic acid-mediated intracellular protein delivery by lipid-like nanoparticles.

P2860

Q26766539-6389E202-9B02-4686-A651-2BEB6DBEDFA0 Q26767097-D8B1659D-6CA0-4A31-9D5F-209C4B864858 Q30400144-E63D78B5-CA90-42A3-A48C-FDD88A796AE8 Q31106232-BA6F8685-F15E-4A55-882F-09675F9DD80E Q32175658-44FF51EA-4C1F-4B01-8C8E-D3949BC4FDA7 Q33565296-681857B2-0EB8-4D24-AA35-4828B4561AE5 Q33624332-561A4FEC-F47E-4858-8F70-DBAF7B097B3E Q33669280-6D268DEB-6421-4F40-9EA5-7D3531495369 Q33733590-29FB0955-AEB4-44BD-88A2-FE96D6F03C5B Q33768763-0C9B9D88-2340-426B-BE8E-1A897540C87B Q33946847-2EF158B4-A880-4D58-816C-94B14E2FBB71 Q34180779-40F950ED-62D9-4756-9B50-F7B294E23CE0 Q34268613-23062CD3-E1A4-4154-A7FE-E2940366F612 Q34296994-DCB1BDDC-14ED-4F5F-A9E8-F0C1EB682850 Q34455041-41692469-47C0-4D4C-9237-7BA3C75B6BEE Q34576021-8EDE79B0-76E7-4804-9EED-205D7A2B69AC Q34607450-C4745A44-7C6C-4159-B8A0-D888476F5934 Q34984874-631144BB-0087-45CC-9EAB-FF87C9D656D9 Q35165017-5BBEF417-9702-490F-AC5C-4316CD01DDFE Q35456892-ADB23425-08E2-45A3-8055-6BB906F5FAFE Q35666220-2E6965A9-D290-4906-8E36-1E0A48E21BD8 Q36191163-8B0638C0-F320-4CB1-82B7-84F31F5E4E98 Q36456012-E464F3CD-34BA-4DD9-B0B0-3B10888177ED Q36553255-F9293C88-EE96-4C4B-95E0-8747C896AD8E Q36618500-E1BADA83-1FEC-4A0C-83C0-BA01ABC1F032 Q37062606-85F32769-89C5-4143-8895-547DD9D4CAAF Q37067211-E6E81F8D-EC03-4B78-B3D4-1B3884B4E293 Q37152397-C1C226A5-E4A0-410A-AA9C-098FACC9EDEF Q37159697-03E7943D-F22F-4328-982C-04D680E745F5 Q37205125-27B1DCDC-E83A-49D8-9848-802CD2C23C70 Q37229386-481F6DE0-4457-4A91-89B0-87458ECC6854 Q37325317-0EA84C87-0AE1-42CF-87AC-D5A854E4EAF8 Q37354840-93A9A67B-BB17-421A-9ECC-D8799A5D07F0 Q37398348-90843B00-968D-4CD2-A2A3-43ED7C80152D Q37401744-6CF2539E-0A0E-4225-907F-40CAB945F6CB Q37416593-6BA210E3-F88C-4355-9745-875B93D5E1F1 Q37463831-184556FB-B4FA-4EA5-B6D4-061E998F49D2 Q37477387-92174914-5C5E-45C7-9A2C-F00CF73A198F Q37530378-62B452EC-EA6C-4333-B356-3BD300C165CE Q37602237-BC47F83E-37CB-42DC-9B4B-BCFAEC2D1F64

P2860

Nanoparticles and microparticles as vaccine-delivery systems.

http://www.wikidata.org/entity/Q36968297

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Nanoparticles and microparticles as vaccine-delivery systems.

@en

type

label

Nanoparticles and microparticles as vaccine-delivery systems.

@en

prefLabel

Nanoparticles and microparticles as vaccine-delivery systems.

@en

P1433

Q36968297-80523856-3702-4FD4-9C8D-CF66DA223A93

P1476

Q36968297-44144B42-CAFB-4A16-ADD3-2F8C8CCF2591

P2093

Q36968297-65AA44E6-1767-4274-BCF7-BBA742D25490

Q36968297-901B8E0D-DC79-4744-8171-624D3CD4F938

Q36968297-BCC225EF-F0FD-4814-A774-477FECA06DEA

P2860

Q36968297-00757933-29E0-4D6A-9ED3-8D251298C253

Q36968297-07EA7355-4DA9-4876-8265-F18D2647EE0D

Q36968297-0AEA9433-488D-4377-9771-228DD8F99463

Q36968297-12690C46-A67D-43E9-A4C4-25D01CBC3F7C

Q36968297-12919AF8-33A3-4696-A2C2-127ABD0D6991

Q36968297-15C2914E-8674-4886-A576-E173E175A8DE

Q36968297-1617FC14-3F50-42A2-A03F-866830BE12C3

Q36968297-170076AD-13DD-4C12-B430-E705BBAB9542

Q36968297-17E52AFC-5EBA-4504-AD94-688396ABA743

Q36968297-1A3D9C1D-D53B-4370-A7E0-E78A6430F80A

P304

Q36968297-AA2EC275-F421-44D3-97FF-D99BE579796D

P31

Q36968297-B79222CC-AA0E-4CE1-A83F-2CD9A4AEE66E

P356

Q36968297-C1784B2D-6AC0-446D-9006-B54E8C6E81C2

P433

Q36968297-DBAFC46A-B557-42C5-878C-8AA351A18C0D

P478

Q36968297-3D220936-36EC-4767-8E79-0D0F9CEADFEA

P577

Q36968297-167F5DD0-2CBB-48F2-B960-092564224128

P698

Q36968297-74848090-342C-46BA-8AF0-BE324AAEC32C

P921

Q36968297-1C6209DB-291E-4A38-9CDF-714D36666716

P356

14760584.6.5.797

P1433

Expert Review of Vaccines

P1476

Nanoparticles and microparticles as vaccine-delivery systems.

@en

P2093

Aravind Chakrapani

http://www.w3.org/2001/XMLSchema#string

Derek O'Hagan

http://www.w3.org/2001/XMLSchema#string

Manmohan Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene

Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.

Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.

Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation

Ambiguities in the preclinical quality assessment of microparticulate vaccines.

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles

The instructive role of innate immunity in the acquired immune response.

Microparticle vaccine approaches to stimulate mucosal immunisation.

P304

797-808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.6.5.797

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17931159

http://www.w3.org/2001/XMLSchema#string

P921